Brief Summary:

This study aims to evaluate the topical safety, tolerability, and efficacy of a combined skincare regimen for anti-aging purposes. The investigation targets improvements in wrinkles, fine lines, pore size, and elasticity over a period of 30 days of standard usage. Adult participants will be involved in the assessment of investigational products, focusing on safety parameters, and clinical efficacy, as well as instrumental evaluations of pore size, elasticity, wrinkles, and fine lines. 

Complete the form below to be considered for the trial. 

Eligibility Criteria:

• Ages Eligible for Study: 35 to 60 
• Sexes Eligible for Study: All  Healthy Volunteers: Yes

Inclusion Criteria:

• Female age 35 and older
• Must be in good general health
• Must be willing to use follow skincare regimen 2 times a day
• Must be willing to avoid tanning beds and excessive exposure to direct sunlight
• Must be willing to continue using the regular cosmetic regimen
• Must be willing to complete a user survey
• Must be willing to sign photo-release
• Must be willing to sign consent

Exclusion Criteria:

• Subjects who have used retinol 7 days prior to study commencement
• Acne Skin
• Nursing, pregnant, or planning a pregnancy during this study
• Having a health condition and/or pre-existing or dormant dermatologic disease on the face 
• Nursing pregnant/ planning to become pregnant during the course of the study
• Using a medication that increases sensitivity to sunlight including doxycycline, minocycline, tetracycline, ciprofloxacin, hydrochlorothiazide, and sulfonamides.
• Any known allergies/sensitivities to facial skincare products, anti-aging products, depigmenting products, or products containing hydroquinone
• Usage of any new skincare products during the course of the study
• Presence of atopic dermatitis or psoriasis on the face
• Uncontrolled diabetes, hypertension, hypothyroidism, hyperthyroidism
• TCA or other deep peels within 3 months or medium to light peels within 1 month prior to starting the study
• Facial/laser treatment within the last 1 months
• Facial cosmetic surgery within the last 6 months
• Use of product, topical, or systemic medication, known to affect dyschromia, having “whitening” or anti-aging properties
• Physical skin conditions such as excessive hair, scarring, and tattoos that might impair evaluations of the test sites
• Active hepatitis, immune deficiency, or autoimmune disease